Introduction
Histidine-rich glycoprotein (HRGP) is an abundant 67 kDa plasma glycoprotein identified in many vertebrates and also in invertebrates, such as the blue mussel, Mytilus edulis [1, 2] . The protein is a member of the cystatin super family, along with kininogen, α-2-HS-glycoprotein and cystatin. HRGP is synthesized in the liver, found in plasma and is stored in the α-granules of thrombocytes, from which it is secreted upon thrombin activation [3] . The concentration in human plasma is ~ 2 µM but the local concentration, close to thrombocytes activated during coagulation, is likely to be higher, reaching levels of 10-50 µM [4] . HRGP contains two cystatin-like domains, a central histidine-rich region (HRR) containing multiple GHHPH tandem repeats flanked by proline-rich regions, and a C-terminal region [4] . HRGP interacts, either via the HRR or other domains, with multiple ligands, such as heparan sulphate, heme, fibrinogen, thrombospondin, plasminogen, IgG, FcγR and C1q. Notably, the HRR of HRGP binds to heparan sulphate as well as heparin and this interaction is strongly enhanced in the presence of Zn 2+ and at acidic conditions [4, 5] .
Antimicrobial peptides (AMP) are important effector molecules of innate immunity [6] .
AMPs interact with bacterial membranes, leading to membrane destabilization, intracellular changes and ultimately, bacterial killing [7] [8] [9] . Besides their antibacterial effects, additional biological effects exerted by AMPs include stimulation of growth and angiogenesis (angiogenins, LL-37), protease inhibition (SLPI), anti-angiogenesis (PR-39), and chemotaxis (chemokines, LL-37, defensins) [10, 11] . As recently shown by our group, AMPs and heparin-binding peptides share many structural and functional features. This applies to classical AMPs, such as LL-37 and defensin, as well as the anaphylatoxin C3a, domain 5 of high molecular weight kininogen, and also several other heparin-binding peptides derived from protein C inhibitor and other plasma and matrix proteins [12] [13] [14] . In conjunction with these findings, consensus heparin-binding peptide sequences (Cardin and Weintraub motifs) XBBBXXBX or XBBXBX (where X represents hydrophobic or uncharged amino acids, and B represents basic amino acids), represented by multiples of the motifs ARKKAAKA or AKKARA [15] , were shown to be antibacterial [16] and specifically interact with membranes [17] . Furthermore, recent studies have shown that Cardin motif peptides having R and K
replaced by H, thus yielding peptides containing the sequences AHHAHA and AHHHAAHA, are antibacterial in the presence of Zn 2+ or in low pH [18] .
The observation that the HRR of HRGP shares many functional (heparin binding and multifunctionality) and structural features (multiple GHHPH motifs resembling the heparin binding Cardin peptides), lead us to hypothesize that HRGP, or domains thereof, might possess antibacterial activities. Here we demonstrate that HRGP, as well as an HRR-derived peptide containing the GHHPH motif, exert pH and Zn 2+ dependent antibacterial activities.
Results
Human serum HRGP was purified using Ni-NTA agarose and the molecular weight and purity of the protein was confirmed by SDS-PAGE and western blot (Fig. 1A ).
Aminoterminal sequencing of the ~70 kDa protein yielded the amino acids VSPTD, thus confirming the identity of the protein. Next, the salt-dependence of the bacterial killing was investigated. As presented in Table 1, HRGP-mediated bacterial killing was partly inhibited at 50 mM NaCl, and 150 mM NaCl completely abrogated the antibacterial effects. We also investigated the effect of plasma proteins on the antibacterial action of HRGP. As demonstrated (Fig. 1F) , HRGP (at 4 µM) retained its antibacterial activity in presence of 20% citrate plasma or serum, however, EDTA plasma appeared to inhibit the antibacterial effects. This is possibly due to the chelating effects of EDTA on the Zn 2+ present in the plasma. It should be pointed out that the plasma and serum fractions were diluted in a low salt buffer (10 mM Tris, pH 7.4). Furthermore, as the concentration of HRGP in blood is ~2-3 µM, the final HRGP concentration in the experiments with serum or plasma was ~4.5 µM (4 µM purified HRGP combined with ~0.5
µM from serum and plasma). To exclude the possibility that contaminants in the HRGP preparation were responsible for the antibacterial activity of this molecule, recombinant human HRGP (rHRGP) was produced in human embryonic kidney cells and tested for antibacterial effects. As is the case for the purified HRGP, rHRGP was antibacterial against E.
faecalis, and the activity was dependent on Zn 2+ or low pH (Fig. 1G ). HBP was antibacterial at pH 7.4 (Fig. 2C) . The antibacterial activity of histatin 5 and HRGP was lost in 0.15 M NaCl (at pH 5.5), and no significant difference in activity was found between the two molecules. HBP retained ~50% of its antibacterial activity in 0.15 M NaCl (Fig. 2D ).
Many AMPs kill bacteria by membrane lysis, others may translocate through membranes and subsequently interact with intracellular targets, such as DNA and mitochondria, resulting in bacterial killing [20, 21] . Electron microscopy analysis after negative staining of whole bacteria demonstrated that HRGP triggered membrane destabilization and release of cytoplasmic components (Fig. 3 ). This effect was only observed in 10 mM Tris, pH 7.4 in the presence of 50 µM Zn 2+ (Fig. 3E ) or in 10 mM MES, pH 5.5 ( Fig. 3F ), but not in these respective buffers without HRGP (Fig. 3A-C) or without Zn 2+ (Fig. 3D) . tandem repeats of five consensus sequences of amino acids, GHHPH [4] . Notably, this motif is highly conserved among various vertebrate species (Fig. 5C ). In order to determine whether this sequence motif binds to heparin, a 20-mer peptide (GHHPH) 4 ( Fig. 5C ) was synthesized and tested for heparin-binding ( Fig. 4D ) using an established slot-blot screening assay [12] .
The results showed that the interaction between the GHH20 peptide and heparin was potentiated in the presence of Zn 2+ and also at pH 5.5. Analogous results were obtained with HRGP ( Fig. 4D ). As demonstrated by fluorescence microscopy analysis, the GHH20 peptide showed enhanced binding to the bacterial cells in presence of Zn 2+ (Fig. 4E ), and the binding was completely blocked by heparin. In antibacterial assays the GHH20 peptide exerted antibacterial activities against E. faecalis 2374 in the presence of Zn 2+ or at pH 5.5, albeit at higher concentrations than those required for HRGP-mediated killing. The E. coli isolate was highy sensitive to GHH20 at pH 5.5 ( Fig. 4F ).
Discussion
The main and novel finding in this report is that HRGP, an abundant plasma protein, exerts an antibacterial activity that is facilitated by low pH as well as the cation Zn [23] and the ergot fungus Verticillium kibiense [24] . Furthermore, poly-Lhistidine, as well as the the 25-mer peptide (GHHPH) 5 of HRGP has been shown to bind and neutralise LPS [25] . Although the focus in that study was on endotoxin-neutralization, it is interesting to note that LPS is the major constituent of Gram-negative cell walls, and hence, the observation is compatible with our presented findings on the antibacterial activity of the GHH20 peptide. Clearly, several lines of evidence point to the HRR of HRGP as one effector of antimicrobial activity. However, the data does not rule out the presence of other antimicrobial regions in the protein, or that conformational changes mediated by HRR interactions, lead to the exposure of additional antimicrobial epitopes within the molecule.
It is well established that many AMPs are generated by proteolysis of larger, and nonantimicrobial holoproteins, and this illustrates a common theme in innate immunity. For example, the cathelicidin LL-37 is released from hCAP18, and other AMPs are proteolytically generated from complement factor C3 and high molecular weight kininogen [6, 13, 14] .
Interestingly, the fact that HRGP efficiently kills bacteria, indicates that proteolysis of HRGP is not required for antibacterial activity. Notably, like HRGP, several antimicrobial proteins exert antimicrobial functions per se, and this includes bacterial permeability increasing protein, serprocodins such as proteinase 3, elastase and HBP (used herein for comparison), as well as lactoferrin [26] .
Antibacterial proteins, such as BPI and lactoferrin, may give rise to peptides exerting antibacterial activities [27, 28] . Clearly, the possibility that HRGP may release antibacterial peptides needs to be addressed in future studies. The fact that the HRGP-derived peptide GHH20 was antibacterial, exemplifies that the holoprotein is not a prerequisite for antibacterial action. Interestingly, data are emerging that proteolysis of HRGP may generate bioactive fragments involved in antiangiogenesis [22, 29] . Analogously, recent data indicate that human plasmin, as well as human neutrophil enzymes such as elastase, efficiently degrade HRGP, yielding peptides containing the GHH20-epitope (Rydengård, in preparation).
This represents a proof of the concept that endogenously produced peptides of HRGP may indeed function as AMPs.
Considering the influence of pH and Zn 2+ on the antibacterial activity of HRGP, it is interesting to note that similar Zn 2+ and pH dependence has been demonstrated for many ligands of HRGP, such as cell surface heparan sulphate and tropomyosin [30, 31] . Indeed, it has been proposed that HRGP acts as a pH and Zn 2+ sensor, providing a mechanism for the regulation of the various activities of HRGP, such as antiangiogenesis [5, 32] . Therefore, it is interesting to note that organs such as the skin have a low pH (pH~ 5), and that acidic conditions are likely to occur in other biological fluids following oxidative burst response of leukocytes [33] . Furthermore, it is of note that the total concentration of Zn 2+ in plasma is 10-18 µM, but that thrombocytes can accumulate levels of Zn 2+ 25 to 60-fold higher than those found in plasma [34] . Additionally, human skin has been reported to contain significant levels of Zn 2+ (~0.5 mM) [35] . Of relevance to this is the finding that clots generated from normal human plasma exert significantly stronger antimicrobial effects than those observed for HRGP-depleted fibrin clots (Rydengård, in preparation) . Recent data indicate that mice lacking HRGP show enhanced blood coagulation and fibrinolysis [40] . It remains to be investigated whether these animals also have a compromised innate immune response.
Experimental procedures Materials
The peptide GHH20 (GHHPHGHHPHGHHPHGHHPH) was synthesized by Innovagen AB (Lund, Sweden). The purity and molecular weight was confirmed by MALDI-TOF MS analysis (Voyager, Applied Biosystems). 
Purification of human HRGP
Serum HRGP was purified according to Mori et al, with minor changes [41] . Human blood was incubated at room temperature for 1 h, and then centrifuged at 210 x g for 15 minutes.
Twenty ml serum was aspirated and gently shaken at 4ºC together with 2 ml nickel- 
Production and purification of recombinant HRGP (rHRGP and rHRGP1-240)
Full length cDNA encoding human HRGP was cloned into the pCEP-Pu2 expression vector [43] . The truncated version of HRGP containing amino acids 1-240 (HRGP1-240, also previously referred to as His2 [29] was produced by PCR-amplification. A His-tag was Lipofectamine™ (Invitrogen) and selected with 2.5 µg/ml puromycin (Sigma). In order to avoid contamination with bovine HRGP, a defined serum-replacement medium, TCM™ (ICN Biomedicals) was used instead of FCS for collection of conditioned medium. His-tagged HRGP was purified from conditioned medium using Ni-NTA agarose as described above. It is important to note that both rHRGP forms contain 6 aminoterminal histidine residues not found in the endogenous protein.
Western blot
Purified HRGP (~70 ng) was run on 8% SDS-polyacrylamide gels (SDS-PAGE), and subsequently transferred to a nitrocellulose membrane (Hybond-C, GE Healthcare BioSciences, Little Chalfont, UK) [44] . The membrane was incubated with 3% skimmed milk in 10 mM Tris, 0.15 M NaCl, pH 7.4 for 1 hour at room temperature, followed by an incubation for 1 hour with rabbit polyclonal antibodies against GHH20 (diluted 1:1000 in the same buffer). The membrane was washed 3 times, and incubated for 1 hour with horseradish peroxidase-conjugated secondary swine anti rabbit antibodies diluted 1:1000 (Dako, Carpinteria, CA). The image was developed using the ECL system (Amersham Biosciences). , in the presence or absence of heparin (50 µg/ml) for 2 hours at 37°C, centrifuged and the pellet was washed three times with 10 mM Tris, pH 7.4. The pellet and the supernatant were resuspended in SDS sample buffer, run on an 8% SDS-PAGE, and then transferred to a nitrocellulose membrane. Western blotting was performed as previously described.
Initial studies using western blot analysis showed that the GHH-antibodies

Heparin-binding assay
The radioiodination of heparin (from porcine intestinal mucosa, Sigma) was performed according to previous protocols [45, 46] . Two and 5 µg of GHH20 or purified serum HRGP was applied to nitrocellulose membranes (Hybond-C) using a slot blot apparatus. The membranes were incubated with 125 I radiolabelled heparin (10 µg/ml) for 1 hour at room temperature in 10 mM Tris, pH 7.4 (with or without 50 µM Zn 2+ ), or in 10 mM MES, pH 5.5.
The membranes were washed 3 x 10 minutes in the corresponding buffer. A Bas 2000 radio imaging system (Fuji) was used to visualize the radioactive signal.
Fluorescence microscopy
E. faecalis was grown in TH medium at 37ºC to the mid-logarithmic phase of growth. The bacteria were washed in 10 mM Tris, pH 7.4, and resuspended in the same buffer. E. faecalis (2 x 10 6 / ml) was incubated with 2 µg of TAMRA-labelled GHH20 (2 mg/ml) in 10 mM Tris, Figure legends 
